patients
Blood glucose was reduced in all patients       with both doses of GLP-1; plasma C-peptide increased (p<0.02), and plasma       glucagon decreased (p<0.02) compared with basal levels, also in three patients       with normoglycemia and high levels of presumably exogenous insulin.
 @OBJECT$  was reduced  @PREDICAT$  all  @SUBJECT$        with both doses of GLP-1; plasma C-peptide increased (p<0.02), and plasma       glucagon decreased (p<0.02) compared with basal levels, also in three patients       with normoglycemia and high levels of presumably exogenous insulin.